Gut microbiome structure and metabolic activity in inflammatory bowel disease

被引:0
|
作者
Eric A. Franzosa
Alexandra Sirota-Madi
Julian Avila-Pacheco
Nadine Fornelos
Henry J. Haiser
Stefan Reinker
Tommi Vatanen
A. Brantley Hall
Himel Mallick
Lauren J. McIver
Jenny S. Sauk
Robin G. Wilson
Betsy W. Stevens
Justin M. Scott
Kerry Pierce
Amy A. Deik
Kevin Bullock
Floris Imhann
Jeffrey A. Porter
Alexandra Zhernakova
Jingyuan Fu
Rinse K. Weersma
Cisca Wijmenga
Clary B. Clish
Hera Vlamakis
Curtis Huttenhower
Ramnik J. Xavier
机构
[1] Broad Institute of MIT and Harvard,Department of Biostatistics
[2] Harvard School of Public Health,Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease
[3] Novartis Institute for Biomedical Research Inc.,Department of Immunology, K.G. Jebsen Coeliac Disease Research Centre
[4] Massachusetts General Hospital and Harvard Medical School,Center for Microbiome Informatics and Therapeutics
[5] Department of Gastroenterology and Hepatology,undefined
[6] University of Groningen and University Medical Center Groningen,undefined
[7] Department of Genetics,undefined
[8] University of Groningen and University Medical Center Groningen,undefined
[9] Novartis Institute for Biomedical Research Inc.,undefined
[10] Department of Pediatrics,undefined
[11] University of Groningen and University Medical Center Groningen,undefined
[12] University of Oslo,undefined
[13] Massachusetts Institute of Technology,undefined
来源
Nature Microbiology | 2019年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The inflammatory bowel diseases (IBDs), which include Crohn’s disease (CD) and ulcerative colitis (UC), are multifactorial chronic conditions of the gastrointestinal tract. While IBD has been associated with dramatic changes in the gut microbiota, changes in the gut metabolome—the molecular interface between host and microbiota—are less well understood. To address this gap, we performed untargeted metabolomic and shotgun metagenomic profiling of cross-sectional stool samples from discovery (n = 155) and validation (n = 65) cohorts of CD, UC and non-IBD control patients. Metabolomic and metagenomic profiles were broadly correlated with faecal calprotectin levels (a measure of gut inflammation). Across >8,000 measured metabolite features, we identified chemicals and chemical classes that were differentially abundant in IBD, including enrichments for sphingolipids and bile acids, and depletions for triacylglycerols and tetrapyrroles. While > 50% of differentially abundant metabolite features were uncharacterized, many could be assigned putative roles through metabolomic ‘guilt by association’ (covariation with known metabolites). Differentially abundant species and functions from the metagenomic profiles reflected adaptation to oxidative stress in the IBD gut, and were individually consistent with previous findings. Integrating these data, however, we identified 122 robust associations between differentially abundant species and well-characterized differentially abundant metabolites, indicating possible mechanistic relationships that are perturbed in IBD. Finally, we found that metabolome- and metagenome-based classifiers of IBD status were highly accurate and, like the vast majority of individual trends, generalized well to the independent validation cohort. Our findings thus provide an improved understanding of perturbations of the microbiome–metabolome interface in IBD, including identification of many potential diagnostic and therapeutic targets.
引用
收藏
页码:293 / 305
页数:12
相关论文
共 50 条
  • [41] Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridium difficile infection
    Yu, S.
    Ge, X.
    Tan, B.
    Tian, B.
    Shi, Y.
    Dai, Y.
    Hu, S.
    Li, Y.
    Qian, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1031 - 1031
  • [42] THE GUT MICROBIOME REGULATES EFFICACY OF SULFASALAZINE THERAPY FOR SPONDYLOARTHRITIS IN INFLAMMATORY BOWEL DISEASE
    Lima, Svetlana
    Rupert, Amanda
    Jin, Wenbing
    Viladomiu, Monica
    Pires, Silvia
    Woo, Viola
    Putzel, Gregory
    Marderstein, Andrew
    Funez-dePagnier, Gabriela
    Yang, Wei
    Guo, Chun-Jun
    Scherl, Ellen
    Longman, Randy
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S72 - S73
  • [43] THE GUT MICROBIOME REGULATES EFFICACY OF SULFASALAZINE THERAPY FOR SPONDYLOARTHRITIS IN INFLAMMATORY BOWEL DISEASE
    Lima, Svetlana
    Rupert, Amanda
    Jin, Wenbing
    Viladomiu, Monica
    Pires, Silvia
    Woo, Viola
    Putzel, Gregory
    Marderstein, Andrew
    Funez-dePagnier, Gabriela
    Yang, Wei
    Guo, Chun-Jun
    Scherl, Ellen
    Longman, Randy
    GASTROENTEROLOGY, 2023, 164 (04) : S93 - S93
  • [44] GUT MICROBIOME FOR PREDICTION OF INFLAMMATORY BOWEL DISEASE: A MACHINE LEARNING BASED APPROACH
    Joshi, Varun C.
    Raghunathan, Nalini
    Mekala, Dhanush
    Patel, Rajendra
    Godbole, Shubhankar P.
    Banerjee, Rupa
    GASTROENTEROLOGY, 2024, 166 (05) : S561 - S562
  • [45] Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance
    Fiorindi, Camilla
    Russo, Edda
    Balocchini, Lucrezia
    Amedei, Amedeo
    Giudici, Francesco
    NUTRIENTS, 2022, 14 (19)
  • [46] Dietary manipulation of the gut microbiome in inflammatory bowel disease patients: Pilot study
    Olendzki, Barbara
    Bucci, Vanni
    Cawley, Caitlin
    Maserati, Rene
    McManus, Margaret
    Olednzki, Effie
    Madziar, Camilla
    Chiang, David
    Ward, Doyle, V
    Pellish, Randall
    Foley, Christine
    Bhattarai, Shakti
    McCormick, Beth A.
    Maldonado-Contreras, Ana
    GUT MICROBES, 2022, 14 (01)
  • [47] Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
    Yu, Si
    Ge, Xiaomeng
    Xu, Hui
    Tan, Bei
    Tian, Bowen
    Shi, Yujie
    Dai, Yimin
    Li, Yue
    Hu, Songnian
    Qian, Jiaming
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [48] Exploring the Gut Microbiome's Role in Inflammatory Bowel Disease: Insights and Interventions
    Gyriki, Despoina
    Nikolaidis, Christos
    Stavropoulou, Elisavet
    Bezirtzoglou, Ioanna
    Tsigalou, Christina
    Vradelis, Stergios
    Bezirtzoglou, Eugenia
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (05):
  • [49] The Gut Microbiome and the Triple Environmental Hit Concept of Inflammatory Bowel Disease Pathogenesis
    Kellermayer, Richard
    Zilbauer, Matthias
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (05): : 589 - 595
  • [50] Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease
    Xia, Y.
    Wang, J.
    Fang, X.
    Dou, T.
    Han, L.
    Yang, C.
    JOURNAL OF APPLIED MICROBIOLOGY, 2021, 131 (06) : 3018 - 3031